Traumatic brain injury (TBI) is one of the leading causes of death and morbidity worldwide especially in industrialized countries. 1 TBI has become a major public health concern with a global prevalence that has escalated to almost 27.08 million people in 2016 as reported by the Global Burden of Diseases, Injuries, and Risk Factors (GBD) study. 2 The study also stated that about 8.1 million people were living with long-term disability caused by TBI, mainly due to falls and motor vehicle accidents. Traumatic brain injury has also been alarmingly related to a number of adverse long-term effects, including elevated risk toward long-term complications such as Parkinson's disease, Alzheimer's disease, Dementia Pugilistica, and posttraumatic epilepsy. 3 TBI is comprised of two phases which are the primary and secondary injury phase. The primary injury phase is the initial impact encountered from the external mechanical force that results in blood vessel damage, axonal tearing, 4 cell death at the injury site, blood-brain barrier disruption, presence of edema, and generation of damage-associated molecular patterns (DAMPs). 5